摘要
目的分析补肺汤在治疗支气管哮喘慢性持续期中的临床价值。方法选取2014年1月—2015年1月所收治的150例支气管哮喘慢性持续期患者为研究对象,将其随机分为对照组和治疗组各75例。对照组采用舒利迭吸入治疗,治疗组采用补肺汤治疗,对比分析两组的临床疗效及肺功能指标。结果经过治疗,治疗组FEV1、FVC等肺功能指标改善情况明显优于对照组,差异有统计学意义(P<0.05)。治疗组临床疗效为94.7%,明显高于对照组78.7%,差异有统计学意义(χ2=7.143,P<0.05)。结论在支气管哮喘慢性持续期,采用补肺汤治疗,能够有效改善患者的肺功能及血气指标,提高临床疗效,值得临床推广使用。
Objective To analyze the clinical value of Bufei decoction in the treatment of bronchial asthma of chronic persistent. Methods150 cases of patients with bronchial asthma of chronic persistent from January 2014 to January 2015 were selected as research objects.They were randomly divided into control group and treatment group, and each group had 75 cases. The control group was treated with Seretide inhalation therapy. The treatment group received Bufei decoction. The clinical efficacy and lung function of the two groups were compared and analyzed. Results After treatment, the improvements of FEV1, FVC and other indicators in lung function of the treatment group was obviously better than those of the control group, and the difference was statistically significant（P〈0.05）. The clinical efficacy of the treatment group was 94.7%, and it was significantly higher than 78.7% of the control group, and the difference was statistically significant（χ^2= 7.143, P〈0.05）. Conclusion Bufei decoction in the treatment of bronchial asthma of chronic persistent can improve lung function, blood gas index and clinical efficacy, and is worthy of clinical use.
出处
《中国中医药现代远程教育》
2015年第12期146-147,共2页
Chinese Medicine Modern Distance Education of China
关键词
补肺汤
支气管哮喘
慢性持续期
中医药疗法
Bufei decoction
bronchial asthma
chronic persistent
therapy of TCM
